Filing Details

Accession Number:
0001571049-15-001279
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-19 17:03:05
Reporting Period:
2015-02-17
Filing Date:
2015-02-19
Accepted Time:
2015-02-19 17:03:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069899 Phibro Animal Health Corp PAHC Pharmaceutical Preparations (2834) 131840497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603461 A Daniel Welch 300 Frank W. Burr Blvd., Ste 21
Teaneck NJ 07666-6712
Sr Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2015-02-17 4,000 $11.83 4,000 No 4 M Direct
Class A Common Stock Disposition 2015-02-17 4,000 $31.90 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Option to purchase Class A Common Stock Disposition 2015-02-17 4,000 $0.00 4,000 $11.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,100 2012-03-01 2019-02-28 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2014.
  2. Reflects the weighted average sale price of the Class A Common Stock sold. The shares were sold in multiple trades at prices ranging from $31.01 to $32.65 per share. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.